Lv5
880 积分 2023-12-06 加入
Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials
3天前
已完结
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
17天前
已完结
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
17天前
已完结
Dose Optimization to Mitigate the Risk of CRS with Elranatamab in Multiple Myeloma
17天前
已关闭
Dose Optimization to Mitigate the Risk of CRS with Elranatamab in Multiple Myeloma
17天前
已关闭
Dermatologic Toxicities of Antibody-Drug Conjugates
19天前
已完结
Postoperative pain-related outcomes and perioperative pain management in China: a population-based study
19天前
已完结
Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
21天前
已完结
Gender difference in the pharmacokinetics and metabolism of VX‐548 in rats
2个月前
已完结
Targeted therapies in patients with newly diagnosed glioblastoma—A systematic meta‐analysis of randomized clinical trials
2个月前
已完结
皖公网安备34019202002308
